ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Monitoring"

  • 2016 American Transplant Congress

    Relationship Between Mean Fluorescence Intensity and C1q/C3d-Fixing Capacities of Anti-HLA Antibodies.

    G. Claisse,1 L. Absi,2 E. Alamartine,1 N. Maillard,1 C. Mariat.1

    1Centre Hospitalier Universitaire - Hôpital Nord, Saint-Etienne, France; 2Laboratoire EFS Loire-Auvergne, Saint-Etienne, France.

    The capacity of anti-HLA antibodies (Abs) to activate complement is thought to be an informative property susceptible to facilitate outcome prediction. Two different tests, C1q-…
  • 2016 American Transplant Congress

    Evaluation of Patient-Reported Nonadherence with Tacrolimus Level Variability in Renal Transplant Recipients.

    N. Parrish,1 T. Kaiser,2 A. McCann,1 J. Aladimi,2 J. Harris,3 A. Govil,2 B. Abu Jawdeh,2 G. Mogilishetty,2 R. Alloway,2 E. Woodle.2

    1Pharmacy Services, University of Cincinnati Medical Center, Cincinnati, OH; 2Medicine, University of Cincinnati, Cincinnati, OH; 3Transplant, University of Cincinnati Medical Center, Cincinnati, OH.

    Medication nonadherence (NA) continues to be a major cause of graft loss post-transplant. Several methods for prospective adherence monitoring have been described including patient interview…
  • 2016 American Transplant Congress

    Detecting Renal Allograft Inflammation Using Quantitative Urine Metabolomics and CXCL10.

    J. Ho,1 A. Sharma,2 R. Mandal,3 D. Wishart,3 C. Wiebe,1 L. Storsley,1 M. Karpinski,1 I. Gibson,4 P. Nickerson,1 D. Rush.1

    1Internal Medicine, University of Manitoba, Winnipeg, MB, Canada; 2Pediatrics & Child Health, University of Manitoba, Winnipeg, MB, Canada; 3Biological Sciences, University of Alberta, Edmonton, AB, Canada; 4Pathology, University of Manitoba, Winnipeg, MB, Canada.

    Background. We studied urine metabolomics (UM) alone or combined with urine CXCL10 to non-invasively detect cellular infiltrates in renal allograft biopsies.Methods. Urines (n=137) were obtained…
  • 2016 American Transplant Congress

    Continuous Glucose Monitoring in the First 6 Weeks After Transplantation in Pancreas Transplant Recipients.

    K. Bonner,1 V. Dadlani,2 P. Thapa,2 M. Stegall,1 Y. Kudva.2

    1Department of Surgery, Division of Transplant Surgery, Mayo Clinic, Rochester; 2Department of Medicine, Division of Endocrinology, Mayo Clinic, Rochester.

    Introduction The maturation of Continuous glucose monitoring (CGM) technology enables accurate characterization of daily glucose control. We investigated glucose control using CGM in the first…
  • 2016 American Transplant Congress

    Vascular Composite Allotransplantation Collaborative Initiative Biobank: Bringing the Power Back to Research.

    J. Cheeseman, M.-B. Joshi, F. Leopardi, R. Osborne, D. Conlon, L. Stempora, M. Song, L. Cendales.

    Surgery, Duke University, Durham, NC.

    Refining Vascular Composite Allotransplantation (VCA) into a useful therapeutic option for patients in need of tissue reconstruction depends on the availability of biological specimens and…
  • 2016 American Transplant Congress

    Urinary Exosomal Annexin A1 Is a Predictive Biomarker of Post Kidney Transplant Complications.

    H. Harada,1 T. Murakami,2 C. Yamamoto,2 K. Hotta,1 N. Fukuzawa,1 M. Mitsuhashi.2

    1Kidney Transplant Surgery, Sapporo City General Hospital, Sapporo, Japan; 2Hitachi Chemical Co. America, Ltd., Irvine, CA; 3Nanosomix, Inc., Aliso Viejo, CA.

    IntroductionMonitoring of kidney allograft condition is important. We had exhibited non-invasive diagnostic modality of post-kidney transplant complications using urine exosomal and microvesicule (EMV) mRNA of…
  • 2016 American Transplant Congress

    NanoString Detection of Gene Signatures in Urine During Acute Cellular Rejection of Kidney Grafts.

    K. Keslar,1 A. Zmijewska,2 J. Andriga,2 K. Newell,3 R. Mannon,2 P. Heeger,4 R. Fairchild.1

    1Cleveland Clinic, Cleveland; 2UAB, Birmingham; 3Emory, Atlanta; 4MSSM, New York.

    Considerable effort has focused on identification of gene expression patterns that may assist in diagnosis of acute cellular rejection. The NanoString platform offers a novel…
  • 2016 American Transplant Congress

    Impact of Ethnicity on Tacrolimus Trough/Dose Ratios Following Solid Organ Transplantation.

    A. Santeusanio, A. Owusu-Obeng, J. Jeff.

    Mount Sinai Hospital, New York.

    Objective: to assess tacrolimus dosing requirements based upon ethnicity in order to help guide future decisions regarding dosage initiation and titration among Hispanic and African…
  • 2016 American Transplant Congress

    Comparison of Actual versus Goal Tacrolimus Levels Post Cardiothoracic Transplant.

    E. Milas, I. Feurer, C. Truscott, J. Gray, N. Wilson, S. Bala, T. Dreher, M. Wigger, M. Steele, A. Shah, E. Lambright, D. Hanto.

    Vanderbilt Transplant Center, Nashville, TN.

    BackgroundAlthough target tacrolimus (TAC) trough levels necessary to prevent rejection are established post heart/lung transplant (tx), there is little published literature on the proportion of…
  • 2016 American Transplant Congress

    Urine IP-10 as the Biomarker for ABMR in Kidney Transplant Recipient with DGF.

    N. Townamchai,1 A. Leelahavanichakul,2 J. Supapol,3 S. Wattanatorn,1 Y. Avihingsanon,1 K. Praditpornsilpa.1

    1Department of Medicine, Division of Nephrology, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand; 2Department of Microbiology, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand; 3Department of Surgery, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.

    Background: In the setting of DGF in kidney transplantation (KT), early acute ABMR, which needs early treatment, has to be differentiated from simple ischemic acute…
  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences